Parametric Portfolio Associates’s Atara Biotherapeutics ATRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$295K Sell
1,269
-951
-43% -$303K ﹤0.01% 3286
2021
Q4
$875K Buy
2,220
+326
+17% +$137K ﹤0.01% 2838
2021
Q3
$848K Sell
1,894
-427
-18% -$153K ﹤0.01% 2872
2021
Q2
$902K Sell
2,321
-275
-11% -$98.1K ﹤0.01% 2818
2021
Q1
$932K Buy
2,596
+608
+31% +$269K ﹤0.01% 3195
2020
Q4
$976K Buy
1,988
+238
+14% +$110K ﹤0.01% 3068
2020
Q3
$567K Buy
1,750
+264
+18% +$89.9K ﹤0.01% 3210
2020
Q2
$541K Buy
1,486
+193
+15% +$48.8K ﹤0.01% 3233
2020
Q1
$275K Sell
1,293
-67
-5% -$21.3K ﹤0.01% 3426
2019
Q4
$560K Buy
1,360
+285
+27% +$98.3K ﹤0.01% 3327
2019
Q3
$380K Buy
+1,075
New +$401K ﹤0.01% 3438
2019
Q2
Sell
-384
Closed -$382K 3958
2019
Q1
$382K Sell
384
-705
-65% -$655K ﹤0.01% 3459
2018
Q4
$945K Sell
1,089
-22
-2% -$20.4K ﹤0.01% 3014
2018
Q3
$1.15M Sell
1,111
-1
-0.1% -$978 ﹤0.01% 3014
2018
Q2
$1.02M Buy
1,112
+27
+2% +$29K ﹤0.01% 3049
2018
Q1
$1.06M Sell
1,085
-627
-37% -$571K ﹤0.01% 2983
2017
Q4
$775K Buy
1,712
+474
+38% +$175K ﹤0.01% 3137
2017
Q3
$512K Buy
1,238
+51
+4% +$19.2K ﹤0.01% 3410
2017
Q2
$415K Buy
1,187
+171
+17% +$65.9K ﹤0.01% 3471
2017
Q1
$522K Buy
1,016
+391
+63% +$162K ﹤0.01% 3188
2016
Q4
$222K Sell
625
-88
-12% -$37.3K ﹤0.01% 3553
2016
Q3
$381K Buy
713
+84
+13% +$45.6K ﹤0.01% 3303
2016
Q2
$354K Buy
+629
New +$302K ﹤0.01% 3378

Other funds holding ATRA